Pyc Therapeutics Ltd has released a press release.
Fourfold Delivery Improvement in a New Lead Candidate
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- R&D Tax Incentive Refund
- Reinstatement to Official Quotation
- Phylogica Recapitalisation
- Suspension from Official Quotation
- Update on Capital Raising
Later from PYC Therapeutics
- Sept 2018 Quarterly Operations Update and App4C
- AGM Company Presentation
- FNA Presentation
- Successful Delivery of CRIPR/Cas9 into Cells ex vivo
- In vivo success - peptide vaccine in Herpes Simplex Virus
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics